BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7491786)

  • 1. Induction by herpes simplex virus of free and heteromeric forms of E2F transcription factor.
    Hilton MJ; Mounghane D; McLean T; Contractor NV; O'Neil J; Carpenter K; Bachenheimer SL
    Virology; 1995 Nov; 213(2):624-38. PubMed ID: 7491786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
    O'Connor RJ; Schaley JE; Feeney G; Hearing P
    Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ADP-ribose) polymerase upregulates E2F-1 promoter activity and DNA pol alpha expression during early S phase.
    Simbulan-Rosenthal CM; Rosenthal DS; Luo R; Smulson ME
    Oncogene; 1999 Sep; 18(36):5015-23. PubMed ID: 10490838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of dihydrofolate reductase gene expression and E2F components in human diploid fibroblasts during growth and senescence.
    Good L; Dimri GP; Campisi J; Chen KY
    J Cell Physiol; 1996 Sep; 168(3):580-8. PubMed ID: 8816912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus induces intracellular redistribution of E2F4 and accumulation of E2F pocket protein complexes.
    Olgiate J; Ehmann GL; Vidyarthi S; Hilton MJ; Bachenheimer SL
    Virology; 1999 Jun; 258(2):257-70. PubMed ID: 10366563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent.
    Armstrong DJ; Roman A
    Virology; 1997 Dec; 239(1):238-46. PubMed ID: 9426463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oswald F; Lovec H; Möröy T; Lipp M
    Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
    Rotheneder H; Geymayer S; Haidweger E
    J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and initial characterization of the BRCA2 promoter.
    Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
    Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus E4 open reading frame 4-induced dephosphorylation inhibits E1A activation of the E2 promoter and E2F-1-mediated transactivation independently of the retinoblastoma tumor suppressor protein.
    Mannervik M; Fan S; Ström AC; Helin K; Akusjärvi G
    Virology; 1999 Apr; 256(2):313-21. PubMed ID: 10191196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in E2F DNA-binding activity during induced erythroid differentiation.
    Richon VM; Venta-Perez G
    Cell Growth Differ; 1996 Jan; 7(1):31-42. PubMed ID: 8788031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A direct role of transcription factor E2F in c-myc gene expression during granulocytic and macrophage-like differentiation of HL60 cells.
    Ishida S; Shudo K; Takada S; Koike K
    Cell Growth Differ; 1995 Mar; 6(3):229-37. PubMed ID: 7794791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transcription factor E2F-1 modulates TGF-beta1 RNA expression in glial cells.
    Thatikunta P; Raj GV; Kundu M; Khalili K; Amini S
    Oncogene; 1997 Jun; 14(24):2959-69. PubMed ID: 9205103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle gene expression and E2F transcription factor complexes in human melanoma cells induced to terminally differentiate.
    Jiang H; Lin J; Young SM; Goldstein NI; Waxman S; Davila V; Chellappan SP; Fisher PB
    Oncogene; 1995 Sep; 11(6):1179-89. PubMed ID: 7566979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of ICP4 repressor activity in temporal expression of the IE-3 and latency-associated transcript promoters during HSV-1 infection.
    Rivera-Gonzalez R; Imbalzano AN; Gu B; Deluca NA
    Virology; 1994 Aug; 202(2):550-64. PubMed ID: 8030221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
    Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
    Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An E2F binding sequence negatively regulates the response of the insulin-like growth factor 1 (IGF-I) promoter to simian virus 40T antigen and to serum.
    Porcu P; Graña X; Li S; Swantek J; De Luca A; Giordano A; Baserga R
    Oncogene; 1994 Aug; 9(8):2125-34. PubMed ID: 8035997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression analysis using DNA microarrays demonstrates that E2F-1 up-regulates expression of DNA replication genes including replication protein A2.
    Kalma Y; Marash L; Lamed Y; Ginsberg D
    Oncogene; 2001 Mar; 20(11):1379-87. PubMed ID: 11313881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the human proopiomelanocortin gene promoter in a small cell lung carcinoma cell line reveals an unusual role for E2F transcription factors.
    Picon A; Bertagna X; de Keyzer Y
    Oncogene; 1999 Apr; 18(16):2627-33. PubMed ID: 10353606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.